PISCATAWAY, N.J., July 17, 2007 - Sabinsa Corporation today announced that it has secured a patent in Japan for its branded ingredient Bioperine(R), a standardized piperine composition derived from black pepper extract. Patent #3953513, Sabinsa's first in Japan, protects the use of piperine as a bioavailability enhancer and affirms that Bioperine is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients.
"Sabinsa pioneered the concept of enhancing nutrient absorption and bioavailability in the early 90s with the development of Bioperine, and we are pleased to be able to protect this intellectual property in the Japanese market," stated Vladimir Badmaev, M.D., Ph.D., vice president of scientific and medical affairs, Sabinsa Corporation. "As the population continues to age, improving nutrient absorption and bioavailability is going to become an even more critical component in helping individuals prevent disease and maintain overall good health."
Bioperine is a standardized piperine composition derived from black pepper extract that has been shown in clinical research to increase the absorption of nutrients in nutritional supplement formulations. Bioperine and its use are protected under U.S. Patent Nos. 5,536,506, 5,744,161, 5,972,382, and 6,054,585; European Patent No. EP0810868; Japanese Patent No. 3953513; and International Patents pending. In 1999, Sabinsa’s U.S. Patent for Bioperine was runner-up for the Thomas Alva Edison Patent Award, given to the most innovative patent of the year by the New Jersey R&D Council. In 2005, a related patent for Bioperine received the Thomas Alva Edison Patent Award. For more information on Bioperine visit www.bioperine.com.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit www.sabinsa.com.
# # #